Navigation Links
FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor
Date:11/30/2011

SILVER SPRING, Md., Nov. 30, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the first generic version of the cholesterol-lowering drug Lipitor (atorvastatin calcium tablets).

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Ranbaxy Laboratories Ltd. has gained approval to make generic atorvastatin calcium tablets in 10 milligram, 20 mg, 40 mg, and 80 mg strengths. The drug will be manufactured by Ohm Laboratories in New Brunswick, N.J.

People who have high blood cholesterol levels have a greater chance of getting heart disease. By itself, the condition usually has no signs or symptoms. Thus, many people do not know that their cholesterol levels are too high.

"This medication is widely used by people who must manage their high cholesterol over time, so it is important to have affordable treatment options," said Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research. "We are working very hard to get generic drugs to people as soon as the law will allow."

Not all cholesterol in your blood is bad. There are three kinds of blood cholesterol that you should know about: high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides. HDL (good cholesterol) helps keep cholesterol from building up in the arteries. LDL (bad cholesterol) is the main source of cholesterol buildup and blockage in the arteries, which can prevent proper blood flow to your heart and lead to a heart attack. Triglycerides can lead to hardening of the arteries.

Atorvastatin is a statin, a type of drug that lowers cholesterol in the body by blocking an enzyme in the liver. Atorvastatin is used along with a low-fat diet to lower the LDL cholesterol and triglycerides in the blood. The drug can raise HDL cholesterol as well. Atorvastatin lowers the risk for heart attack, stroke, certain types of heart s
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves First Insomnia Drug for Middle-of-the-Night Waking Followed By Difficulty Returning to Sleep
2. FDA Approves Eylea for Eye Disorder in Older People
3. FDA Approves First Supplemental Test for Chagas Disease
4. FDA Approves Erwinaze to Treat a Form of Leukemia
5. FDA Approves New York Blood Centers HEMACORD™ for Stem Cell Transplantation
6. FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer
7. FDA Approves Xarelto to Prevent Stroke in People With Common Type of Abnormal Heart Rhythm
8. FDA Approves U.S. Market Return for octagam® Following Octapharmas Implementation of Enhanced Safety Measures
9. FDA Approves First Artificial Aortic Heart Valve Placed Without Open-Heart Surgery
10. FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder
11. FDA Approves Onfi To Treat Severe Type of Seizures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2, 2014  Based on its recent analysis ... Frost & Sullivan recognizes Novian Health, Inc. with ... for Technology Innovation Leadership. Novian Health has greatly ... tumors with its proprietary technology, Novilase ® ... accurate, and easy-to-control ultrasound-guided thermo ablation device that ...
(Date:9/2/2014)... DIEGO , Sept. 2, 2014 ResMed (NYSE: ... and Astral™ 150 devices in the United ... generation of portable, lightweight, and user-friendly life support ventilators. ... offer unparalleled mobility and ease of use for patients ... and other adult and childhood respiratory disorders. The U.S. ...
(Date:9/2/2014)... BEDFORD, Mass. , Sept. 2, 2014  Hologic, Inc. (NASDAQ: ... , President and Chief Executive Officer, will present at the ... City , New York on ... Interested parties are invited to listen to the live ... Hologic,s website at www.hologic.com/investors-overview . An archive of the ...
Breaking Medicine Technology:Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 2Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 3Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 4Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 5ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 2ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 3
... recognizes MedNet Solutions as the first QM Certified ... QualityMetric Incorporated announced today that MedNet Solutions, ... study management systems, is the first company to ... developed the QM Certified Scoring Partner program to ...
... Reports Significant Uptake of PlasmaBlade by U.S. Surgeons ... PEAK Surgical, Inc., a medical device company ... based on a proprietary technology, announced today several ... includes the PULSAR(R) Generator and the PEAK PlasmaBlade(TM) ...
Cached Medicine Technology:MedNet Solutions Certified to Score SF-12v2 Health Survey 2MedNet Solutions Certified to Score SF-12v2 Health Survey 3PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM) 2PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM) 3PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM) 4
(Date:9/2/2014)... (PRWEB) September 02, 2014 As an industry ... in an industry and predict change. Fortunately for him, that ... him to identify markets that are eager for change — ... of the hearing aid market indicated it was ripe for ... consumer,” Sapio explained. As a result, he took matters into ...
(Date:9/2/2014)... is available in Spanish . ... found, through an experiment conducted on rats, that hyperproteic diets ... use for groups with bone disease problems, such as the ... that vegetal proteinin the case of the present study, soy ... the former increased the level of calcium in bones by ...
(Date:9/2/2014)... nurses in their work care for patients who are ... shown that many nurses in training feel unprepared and ... during end-of-life care. , Scientists from the Sahlgrenska Academy ... Gothenburg, the University of Skvde and the Ersta Skndal ... caring for dying patients, their ideas about how to ...
(Date:9/2/2014)... September 02, 2014 Catalent, the ... development solutions for drugs, biologics and consumer health ... strategic partner, Eli Lilly’s growth, it is to ... at its Philadelphia Clinical Supply Center of Excellence. ... capabilities in its clinical supply facility in Schorndorf, ...
(Date:9/2/2014)... Splashtop Inc. , the worldwide ... NTT DoCoMo to deliver Splashtop Business Lite ... Lite is included in NTT DoCoMo’s “Business Plus” program. ... that empower users to remote access their corporate computers ... 18 million users worldwide. Splashtop delivers the best ...
Breaking Medicine News(10 mins):Health News:David Sapio Launches Zounds Hearing Franchise 2Health News:Study conducted on rats suggests that hyperproteic diets can be beneficial for bones 2Health News:Many nurses unprepared to meet dying patients 2Health News:Catalent Supports Eli Lilly's Growing Global Clinical Trials Needs with New Investment in Automated Packaging Solutions 2Health News:Splashtop and NTT DoCoMo Partner to Deliver “Splashtop Business Lite” Secure Remote Access Solution to Business Customers 2
... affect heart despite symptom relief, experts say , , MONDAY, ... longer than they did 40 years ago, but not if ... the Mayo Clinic. , "When you look at persons with ... benefits over the last several decades of improved survival the ...
... for colorectal cancer screening, nearly two-thirds of screening colonoscopies ... in the October issue of the journal Gastroenterology, Thomas ... University School of Medicine and a Regenstrief Institute, Inc. ... who is at risk for colorectal cancer as well ...
... cancer who arent eligible for standard treatment is under ... unfortunate reality is that kidney problems often result from ... cisplatin and gemcitabine, says Dr. Teresa A. Coleman, hematologist-oncologist ... II study at about 120 sites in North America, ...
... Va., Oct. 29 CEL-SCI Corporation,(Amex: CVM ) ... of cancer immunotherapies on its new website. The link ... home page at http://www.cel-sci.com . Geert ... minds of many represents the future of cancer therapy. ...
... - Halogen Software Inc., the leading,provider of Web-based ... Vonage has selected Halogen eAppraisal with,Multi-Rater. Vonage, a ... a Web-based system to streamline the appraisal process ... top-notch services to its,customers. Vonage will be ...
... crisis in the developing world because of lack of ... His Royal Highness The Duke of York, Patron of ... , In the foreword to a special supplement ... The Duke of York says that this situation is ...
Cached Medicine News:Health News:Rheumatoid Arthritis Death Rate Unchanged 2Health News:Rheumatoid Arthritis Death Rate Unchanged 3Health News:1 size may not fit all 2Health News:New treatment option studied for bladder cancer 2Health News:New treatment option studied for bladder cancer 3Health News:Vonage Selects Halogen Software - New Solution to Streamline Employee Performance and Talent Management Across Organization 2Health News:British Royal highlights anesthesia crisis in the developing world 2
... magnifier is an easy to use, full ... so that the monitor (usually a ... magnifier and is not built in. This ... screen if desired in the future. Also ...
... Maxport is a powerful magnifier that helps the ... composed of a hand magnifier attached to a pair ... there is no need for a TV set. The ... magnify images on a book, a can of food, ...
... powerful, portable, hand-held digital magnifier designed for ... a computer mouse, Max connects directly to ... you to read newspapers, magazines, recipe cards ... any surface curved or straight. The optional ...
... Merlin is a superior full-color, auto-focus, ... vision user in mind, Merlin enables the ... black and white, high contrast positive or ... video magnifier, this optional feature enables the ...
Medicine Products: